Skip to main content
logo
KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
20.29
+0.70 (3.57%)
At close: Apr 14, 2026, 4:00 PM EDT
20.61
+0.32 (1.55%)
After-hours: Apr 14, 2026, 6:50 PM EDT

KalVista Pharmaceuticals Revenue

In the year 2025, KalVista Pharmaceuticals had annual revenue of $73.62M. KalVista Pharmaceuticals had revenue of $59.93M in the quarter ending December 31, 2025.

Revenue (ttm)
$73.62M
Revenue Growth
n/a
P/S Ratio
14.12
Revenue / Employee
$267,698
Employees
275
Market Cap
1.04B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202573.62M--
Apr 30, 2025---
Dec 31, 2024---
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022 Pro Pro Pro
Apr 30, 2021 Pro Pro Pro
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xeris Biopharma Holdings291.85M
Phathom Pharmaceuticals175.11M
UroGen Pharma109.79M
CytomX Therapeutics76.20M
Septerna45.95M
Inventiva9.31M
Aktis Oncology6.50M
Compass Therapeutics850.00K
Revenue Rankings

KALV News

More News